Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Research programme: interleukin-1 receptor associated kinase inhibitors - Rigel Pharmaceuticals

Next Previous
Drug Profile

Research programme: interleukin-1 receptor associated kinase inhibitors - Rigel Pharmaceuticals

Alternative Names: IRAK1/4 inhibitors - Rigel Pharmaceuticals; IRAK4 kinase inhibitors - Rigel Pharmaceuticals; R 191

Latest Information Update: 25 Nov 2021

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Rigel Pharmaceuticals; University of Texas M. D. Anderson Cancer Center
  • Class Antineoplastics
  • Mechanism of Action IRAK4 protein inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Chronic myelomonocytic leukaemia; Haematological malignancies; Myelodysplastic syndromes

Most Recent Events

  • 15 Nov 2021 Rigel Pharmaceuticals plans a clinical trial for IRAK1/4 programin
  • 03 Aug 2021 Preclinical development in Haematological malignancies is ongoing in USA
  • 03 Aug 2021 Preclinical trials in Chronic myelomonocytic leukaemia in USA

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top